Alkermes PLC (ALKS)
24.05
+0.19
(+0.80%)
USD |
NASDAQ |
May 03, 16:00
24.06
0.00 (0.00%)
After-Hours: 20:00
Alkermes Free Cash Flow: 394.23M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 394.23M |
| December 31, 2023 | 353.30M |
| September 30, 2023 | 254.12M |
| June 30, 2023 | 159.01M |
| March 31, 2023 | -59.26M |
| December 31, 2022 | -17.21M |
| September 30, 2022 | 14.13M |
| June 30, 2022 | 101.94M |
| March 31, 2022 | 139.71M |
| December 31, 2021 | 72.70M |
| September 30, 2021 | 112.24M |
| June 30, 2021 | 88.07M |
| March 31, 2021 | 47.56M |
| December 31, 2020 | 40.62M |
| September 30, 2020 | -11.18M |
| June 30, 2020 | -53.43M |
| March 31, 2020 | -77.51M |
| December 31, 2019 | -18.86M |
| September 30, 2019 | 13.96M |
| June 30, 2019 | 19.48M |
| March 31, 2019 | 73.75M |
| December 31, 2018 | 29.85M |
| September 30, 2018 | 5.018M |
| June 30, 2018 | -5.388M |
| March 31, 2018 | -54.30M |
| Date | Value |
|---|---|
| December 31, 2017 | -32.11M |
| September 30, 2017 | -52.51M |
| June 30, 2017 | -55.94M |
| March 31, 2017 | -61.36M |
| December 31, 2016 | -107.46M |
| September 30, 2016 | -118.88M |
| June 30, 2016 | -163.52M |
| March 31, 2016 | -153.83M |
| December 31, 2015 | -93.24M |
| September 30, 2015 | -79.19M |
| June 30, 2015 | -54.46M |
| March 31, 2015 | -21.99M |
| December 31, 2014 | -22.51M |
| September 30, 2014 | 12.96M |
| June 30, 2014 | 38.78M |
| March 31, 2014 | 82.80M |
| September 30, 2013 | 115.41M |
| June 30, 2013 | 124.89M |
| March 31, 2013 | 104.33M |
| December 31, 2012 | 64.44M |
| September 30, 2012 | -461.19M |
| June 30, 2012 | -506.50M |
| March 31, 2012 | -514.24M |
| December 31, 2011 | -514.49M |
| September 30, 2011 | -0.719M |
Free Cash Flow Range, Past 5 Years
-77.51M
Minimum
Mar 2020
394.23M
Maximum
Mar 2024
78.68M
Average
44.09M
Median
Free Cash Flow Benchmarks
| Endo International PLC | 340.77M |
| Jazz Pharmaceuticals PLC | 983.48M |
| Medtronic PLC | 4.931B |
| Perrigo Co PLC | 303.80M |
| Iterum Therapeutics PLC | -39.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 21.11M |
| Cash from Investing (Quarterly) | -39.95M |
| Cash from Financing (Quarterly) | -17.87M |
| Free Cash Flow Per Share (Quarterly) | 0.0738 |
| Free Cash Flow to Equity (Quarterly) | 13.40M |
| Free Cash Flow to Firm (Quarterly) | 12.77M |
| Free Cash Flow Yield | 9.60% |